Lipidomics in Major Depressive Disorder

Andreas Walther, Carlo Vittorio Cannistraci, Kai Simons, Claudio Durán, Mathias J Gerl, Susanne Wehrli, Clemens Kirschbaum

Research output: Contribution to journalArticle

Abstract

Omic sciences coupled with novel computational approaches such as machine intelligence offer completely new approaches to major depressive disorder (MDD) research. The complexity of MDD's pathophysiology is being integrated into studies examining MDD's biology within the omic fields. Lipidomics, as a late-comer among other omic fields, is increasingly being recognized in psychiatric research because it has allowed the investigation of global lipid perturbations in patients suffering from MDD and indicated a crucial role of specific patterns of lipid alterations in the development and progression of MDD. Combinatorial lipid-markers with high classification power are being developed in order to assist MDD diagnosis, while rodent models of depression reveal lipidome changes and thereby unveil novel treatment targets for depression. In this systematic review, we provide an overview of current breakthroughs and future trends in the field of lipidomics in MDD research and thereby paving the way for precision medicine in MDD.

Original languageEnglish
Pages (from-to)459
JournalFrontiers in Psychiatry
Volume9
DOIs
Publication statusPublished - 2018

Fingerprint

Major Depressive Disorder
Lipids
Research
Depression
Precision Medicine
Artificial Intelligence
Psychiatry
Rodentia

Cite this

Walther, A., Cannistraci, C. V., Simons, K., Durán, C., Gerl, M. J., Wehrli, S., & Kirschbaum, C. (2018). Lipidomics in Major Depressive Disorder. Frontiers in Psychiatry, 9, 459. https://doi.org/10.3389/fpsyt.2018.00459

Lipidomics in Major Depressive Disorder. / Walther, Andreas; Cannistraci, Carlo Vittorio; Simons, Kai; Durán, Claudio; Gerl, Mathias J; Wehrli, Susanne; Kirschbaum, Clemens.

In: Frontiers in Psychiatry, Vol. 9, 2018, p. 459.

Research output: Contribution to journalArticle

Walther, A, Cannistraci, CV, Simons, K, Durán, C, Gerl, MJ, Wehrli, S & Kirschbaum, C 2018, 'Lipidomics in Major Depressive Disorder', Frontiers in Psychiatry, vol. 9, pp. 459. https://doi.org/10.3389/fpsyt.2018.00459
Walther, Andreas ; Cannistraci, Carlo Vittorio ; Simons, Kai ; Durán, Claudio ; Gerl, Mathias J ; Wehrli, Susanne ; Kirschbaum, Clemens. / Lipidomics in Major Depressive Disorder. In: Frontiers in Psychiatry. 2018 ; Vol. 9. pp. 459.
@article{72ff6477ca944b68b4642cc6831393b5,
title = "Lipidomics in Major Depressive Disorder",
abstract = "Omic sciences coupled with novel computational approaches such as machine intelligence offer completely new approaches to major depressive disorder (MDD) research. The complexity of MDD's pathophysiology is being integrated into studies examining MDD's biology within the omic fields. Lipidomics, as a late-comer among other omic fields, is increasingly being recognized in psychiatric research because it has allowed the investigation of global lipid perturbations in patients suffering from MDD and indicated a crucial role of specific patterns of lipid alterations in the development and progression of MDD. Combinatorial lipid-markers with high classification power are being developed in order to assist MDD diagnosis, while rodent models of depression reveal lipidome changes and thereby unveil novel treatment targets for depression. In this systematic review, we provide an overview of current breakthroughs and future trends in the field of lipidomics in MDD research and thereby paving the way for precision medicine in MDD.",
author = "Andreas Walther and Cannistraci, {Carlo Vittorio} and Kai Simons and Claudio Dur{\'a}n and Gerl, {Mathias J} and Susanne Wehrli and Clemens Kirschbaum",
year = "2018",
doi = "10.3389/fpsyt.2018.00459",
language = "English",
volume = "9",
pages = "459",
journal = "Frontiers in Psychiatry",
issn = "1664-0640",
publisher = "Frontiers Research Foundation",

}

TY - JOUR

T1 - Lipidomics in Major Depressive Disorder

AU - Walther, Andreas

AU - Cannistraci, Carlo Vittorio

AU - Simons, Kai

AU - Durán, Claudio

AU - Gerl, Mathias J

AU - Wehrli, Susanne

AU - Kirschbaum, Clemens

PY - 2018

Y1 - 2018

N2 - Omic sciences coupled with novel computational approaches such as machine intelligence offer completely new approaches to major depressive disorder (MDD) research. The complexity of MDD's pathophysiology is being integrated into studies examining MDD's biology within the omic fields. Lipidomics, as a late-comer among other omic fields, is increasingly being recognized in psychiatric research because it has allowed the investigation of global lipid perturbations in patients suffering from MDD and indicated a crucial role of specific patterns of lipid alterations in the development and progression of MDD. Combinatorial lipid-markers with high classification power are being developed in order to assist MDD diagnosis, while rodent models of depression reveal lipidome changes and thereby unveil novel treatment targets for depression. In this systematic review, we provide an overview of current breakthroughs and future trends in the field of lipidomics in MDD research and thereby paving the way for precision medicine in MDD.

AB - Omic sciences coupled with novel computational approaches such as machine intelligence offer completely new approaches to major depressive disorder (MDD) research. The complexity of MDD's pathophysiology is being integrated into studies examining MDD's biology within the omic fields. Lipidomics, as a late-comer among other omic fields, is increasingly being recognized in psychiatric research because it has allowed the investigation of global lipid perturbations in patients suffering from MDD and indicated a crucial role of specific patterns of lipid alterations in the development and progression of MDD. Combinatorial lipid-markers with high classification power are being developed in order to assist MDD diagnosis, while rodent models of depression reveal lipidome changes and thereby unveil novel treatment targets for depression. In this systematic review, we provide an overview of current breakthroughs and future trends in the field of lipidomics in MDD research and thereby paving the way for precision medicine in MDD.

U2 - 10.3389/fpsyt.2018.00459

DO - 10.3389/fpsyt.2018.00459

M3 - Article

C2 - 30374314

VL - 9

SP - 459

JO - Frontiers in Psychiatry

JF - Frontiers in Psychiatry

SN - 1664-0640

ER -